1. Home
  2. EXAS vs EXPD Comparison

EXAS vs EXPD Comparison

Compare EXAS & EXPD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Exact Sciences Corporation

EXAS

Exact Sciences Corporation

HOLD

Current Price

$103.89

Market Cap

19.7B

Sector

Health Care

ML Signal

HOLD

Logo Expeditors International of Washington Inc.

EXPD

Expeditors International of Washington Inc.

HOLD

Current Price

$147.49

Market Cap

19.6B

ML Signal

HOLD

Company Overview

Basic Information
Metric
EXAS
EXPD
Founded
1995
1979
Country
United States
United States
Employees
N/A
N/A
Industry
Medical Specialities
Oil Refining/Marketing
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
19.7B
19.6B
IPO Year
2000
1995

Fundamental Metrics

Financial Performance
Metric
EXAS
EXPD
Price
$103.89
$147.49
Analyst Decision
Hold
Hold
Analyst Count
17
10
Target Price
$86.62
$131.90
AVG Volume (30 Days)
1.8M
1.3M
Earning Date
04-30-2026
05-05-2026
Dividend Yield
N/A
1.06%
EPS Growth
80.32
4.02
EPS
N/A
5.95
Revenue
$4,144,000.00
$6,920,948,000.00
Revenue This Year
$15.37
$2.70
Revenue Next Year
$12.41
$3.75
P/E Ratio
N/A
$24.24
Revenue Growth
N/A
13.49
52 Week Low
$38.88
$100.47
52 Week High
$104.02
$167.19

Technical Indicators

Market Signals
Indicator
EXAS
EXPD
Relative Strength Index (RSI) 61.72 51.19
Support Level $103.10 $137.00
Resistance Level N/A $148.97
Average True Range (ATR) 0.31 3.41
MACD -0.03 0.62
Stochastic Oscillator 86.96 89.12

Price Performance

Historical Comparison
EXAS
EXPD

About EXAS Exact Sciences Corporation

Exact Sciences, headquartered in Madison, Wisconsin, provides cancer screening and diagnostic test products in the United States and internationally. Exact's Cologuard screening test is a noninvasive stool-based DNA test for colorectal cancer. The company also competes in the precision oncology market with Oncotype DX, a suite of tissue-based genomic tests for estimating recurrence risk and likelihood of benefit from chemotherapy for breast and colon cancer, and OncoExTra, a liquid-based comprehensive genomic profiling test. It also has a pipeline of blood-based tests for molecular residual disease, colorectal cancer screening, and multicancer screening.

About EXPD Expeditors International of Washington Inc.

Based in the US, Expeditors International of Washington is a non-asset-based third-party logistics provider, mainly focused on international freight forwarding. Its offers freight consolidation and forwarding, customs brokerage, warehousing and distribution, purchase order management, vendor consolidation, and numerous other value-added logistics services. It employs sophisticated IT systems and contracts with airlines and ocean carriers to move customers' freight across the globe. The firm operates more than 200 full-service office locations worldwide, in addition to numerous satellite locations. Expeditors derives around 35% of consolidated gross revenue from airfreight, 30% from ocean freight, and 36% from customs brokerage and other services.

Share on Social Networks: